In breast cancer, miR-181 downregulates the expression of PHLPP2 and INPP4B, which elevates the phosphorylation of Akt, resulting in Akt hyperactivation and promoting S-phase entry and cell proliferation [111]. Here, AKT1 is linked to breast cancer.